These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 35313933)

  • 1. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
    Liang SB; Cao HJ; Kong LY; Wei JL; Robinson N; Yang SH; Zhu SJ; Li YQ; Fei YT; Han M; Liu JP
    Front Pharmacol; 2022; 13():904657. PubMed ID: 36091782
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
    Lu X; Zhang S
    Drug Des Devel Ther; 2023; 17():2969-2983. PubMed ID: 37789966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
    Guo X; Xuan M; Zheng H; Qin S; Wu H; Huang S; Wen Z
    Trials; 2021 Jul; 22(1):491. PubMed ID: 34311755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
    Dai YK; Li DY; Zhang YZ; Huang MX; Zhou YL; Ye JT; Wang Q; Hu L
    PLoS One; 2018; 13(2):e0192319. PubMed ID: 29408906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
    Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating effect of TongXie-YaoFang on colonic epithelial secretion
    Yang C; Xiong Y; Zhang SS; An FM; Sun J; Zhang QL; Zhan Q
    World J Gastroenterol; 2016 Dec; 22(48):10584-10591. PubMed ID: 28082810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
    Zheng Y; Ching J; Cheng CW; Lam WC; Chan KL; Zhang X; Lam PY; Wu XY; Zhong LLD; Cao PH; Lo CW; Cheong PK; Lin Z; Koh M; Wu J; Bian ZX
    Chin Med; 2021 Nov; 16(1):117. PubMed ID: 34774080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tongxie Formula Reduces Symptoms of Irritable Bowel Syndrome.
    Fan H; Zheng L; Lai Y; Lu W; Yan Z; Xiao Q; Li B; Tang M; Huang D; Wang Y; Li Z; Mei Y; Jiang Z; Liu X; Tang Q; Zuo D; Ye J; Yang Y; Huang H; Tang Z; Xiao J;
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1724-1732. PubMed ID: 28634136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome.
    Chen X; Yu X; Shi Y; Shen H
    Ann Palliat Med; 2021 Aug; 10(8):9223-9232. PubMed ID: 34488410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
    Ji L; Zhao X; Zhang Y; Zhao P; Gong R; Li F; Huang H
    Medicine (Baltimore); 2022 Mar; 101(9):e28895. PubMed ID: 35244043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial.
    Yang H; Liu X; Peng W; Chen R; Chen Y
    Medicine (Baltimore); 2021 Jan; 100(3):e23887. PubMed ID: 33545956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats.
    Yang C; Zhang SS; Li XL; Wang ZF; Zhao LQ
    World J Gastroenterol; 2015 Mar; 21(10):2912-7. PubMed ID: 25780288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
    Wang XX; Luo RJ; She B; Chen Y; Guo J
    Trials; 2014 Jul; 15():273. PubMed ID: 25002196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial.
    Qi LY; Yang JW; Yan SY; She YF; Hu H; Li Y; Chi LL; Wu BQ; Tu JF; Wang LQ; Liu CZ
    Trials; 2022 Aug; 23(1):711. PubMed ID: 36028847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
    Leighton MP; Lam C; Mehta S; Spiller RC
    Trials; 2013 Jan; 14():10. PubMed ID: 23302220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.